Work in progress: intra-arterial P-32 chromic phosphate for prevention of postoperative liver metastases in high-risk colorectal cancer patients.
- 1 August 1983
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 148 (2) , 555-559
- https://doi.org/10.1148/radiology.148.2.6867356
Abstract
Eight patients with locally extensive colorectal cancer were treated with colloidal P-32 chromic phosphate via the superior mesenteric artery following resection to prevent development of liver metastases. Of the injected dose, < 2% was found in the right atrial blood following the 1st pass through the liver and < 1% in the urine. Therapy was tolerated well by all patients, with no acute complications. Long-term follow-up is needed to determine the effect of P-32 on the liver and the frequency of hepatic metastases.This publication has 5 references indexed in Scilit:
- PREVENTION OF HEPATIC METASTASES BY INTRAVENOUS RADIOACTIVE GOLD1978
- Adjuvant chemotherapy in the surgical treatment of large bowel cancerCancer, 1976
- Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectumCancer, 1976
- Prevention of Liver Metastases by Intravenous RadioisotopesJAMA, 1964
- Distribution and effect of colloidal chromic phosphate (P32) injected into the hepatic artery and portal vein of dogs and manCancer, 1957